Xanomeline/trospium chloride may help improve cognition in patients with acute schizophrenia and cognitive impairment, ...

Chinese regulators have accepted Zai Lab's (NASDAQ:ZLAB) market application for the drug KarXT, also known as xanomeline and ...

Discover the commercial and brand names of the generic drug Trospium Chloride. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to ...

Antagonizes of the effect of acetylcholine on muscarinic receptors in cholinergically innervated organs including the bladder. Parasympatholytic activity reduces the tonus of smooth muscle in the ...

KarXT is an oral, investigational muscarinic agonist comprised of the muscarinic agonist xanomeline and muscarinic antagonist trospium, developed for treating psychiatric and neurological ...

The US regulator has set an action date of 26th September next year for a decision on KarXT, which combines muscarinic agonist xanomeline tartrate and muscarinic antagonist trospium chloride ...

Cambridge Cognition Holdings plc (AIM: COG), the brain health software group, congratulates Bristol Myers Squibb, the global biopharmaceutical company, for its recent FDA approval of Cobenfy (KarXT™ ...